Introduction {#sec1-1}
============

Cholestatic disorders are among the most severe liver diseases in infancy and childhood \[[@ref1]\]. Cholestasis is defined as an impairment of normal bile flow and is divided into extra-hepatic cholestasis and intra-hepatic cholestasis, the latter can be of hepatocanalicular or ductal origin \[[@ref2]\]. Progressive familial intrahepatic cholestases (PFICs) are a spectrum of autosomal liver disorders \[[@ref3]\]. The three types of PFIC have distinctive clinical, biochemical and histological features \[[@ref4]\]. PFIC1 or Byler disease \[[@ref1]\] and PFIC2 or bile salt export pump (BSEP) disease \[[@ref5]\] are associated with a low or normal serum gamma-glutamyl-transpeptidase (GGT) activity, whereas PFIC3 or multidrug resistance protein 3 (MDR3) disease is associated with a high serum GGT activity \[[@ref1]\]. All mentioned genes encode hepatocanalicular transporters. ATP8B1 encodes an amino-phospholipid flippase translocating phospholipids from the outer to the inner leaflet of the plasma membrane; ABCB11 encodes the bile salt export pump, a liver-specific adenosine triphosphate (ATP)-binding cassette transporter; ABCB4 encodes the multidrug resistance protein 3 functioning as a phospholipid floppase translocating phosphatidylcholine from the inner to the outer leaflet of the membrane \[[@ref6],[@ref7]\]. There are several studies on molecular evaluation of three different types of PFIC diseases including sequencing \[[@ref8]\], evaluation of mutations of the genes \[[@ref1],[@ref9]\], locus mapping \[[@ref10]\] and exon characterization \[[@ref11]\]. On the other hand, recent studies show that rare codons have a critical role in protein folding and activity \[[@ref12]\]. However, there is no study about computational biology and bioinformatics evaluation of PFIC. Furthermore, some reports indicate that ribosomal pausing occurs with decrease of tRNAs concentration in rare codons until the rare activated tRNA brings the next amino acid to ensure the independent folding of some regions of polypeptide chains \[[@ref13],[@ref14]\]. Rare codons studies can provide insights into the diseases background and help in problem solving of drug design \[[@ref14]\]. So, the aim of this study is to evaluate the computational biology of PFIC1 with regard to rare codons and mutation leading to disease. These findings may help in operational development of this technology and in elucidating the ATP8B1 folding mechanism, as well as rational design of new and effective drugs.

Material and Methods {#sec1-2}
====================

We studied, for the first time, rare codons in AT8B1_HUMAN and identified the location of these rare codons in the structure of ATP8B1. Detection of rare codons were performed using the ATGme (<http://atgme.org/>), Rare codon calculator (RaCC) (<http://nihserver.mbi.ucla.edu/RACC>), LaTcOm (<http://structure.biol.ucy.ac.cy/latcom.html>), and Sherlocc program (<http://bcb.med.usherbrooke.ca/sherlocc.php>) \[[@ref15]\]. By these analyses, some rare codons were identified and by molecular modeling in the I-TASSER and \[[@ref16]\], the situation of these rare codons were studied using PyMOL Molecular Graphics System (21) and Swiss PDB Viewer software \[[@ref17]\]. In the following, for study of PFIC1 and their relationships with rare codon, the position of some mutation was evaluated in comparison with rare codon.

Detection of Rare Codon in Gene and Protein Structure of ATP8b1 {#sec2-1}
---------------------------------------------------------------

Rare codon detection in ATGme was performed in four steps: (i) Input of ATP8b1 sequence; (ii) Input of the codon usage table of Homo sapiens \[gbpri\]: 93487 CDS's (40662582 codons) that was obtained from the Codon Usage Database ([http://www.kazusa .or.jp/codon/](http://www.kazusa.or.jp/codon/)); (iii) Detection of rare codons. LaTcOm is a new web tool designed for detecting and visualizing rare codon clusters (RCC) \[[@ref18]\]. In this tool, three core RCC detection algorithms are implemented: i) % minimax algorithm, ii) sliding window approach, and iii) a linear-time algorithm named MSS. RCC was used with the following parameters: MSS, Scale: Dong table codon usage \[[@ref19]\], cluster length: 21 and transformation: linear + sigmoid. Then RCC positions were visualized within the submitted sequences.

Study of Rare Codons in Structure of ATP8b1 {#sec2-2}
-------------------------------------------

To investigate the position of mutations and rare codon in the structure of ATP8b1, the 3D structure of this enzyme was modelled by the submission of ATP8b1sequence in the I-TASSER \[[@ref16]\] and Phyre2 web servers. I-TASSER web server was used to generate a total of five most suitable models of target protein. In this web server, 3D models are built based on multiple-threading alignments by LOMETS (Local Meta-Threading-Server) \[[@ref20]\] and interactive template fragment assembly simulations. The models with the best "Confidence Score" and Z-score were chosen by I-TASSER server. Phyre2 web server applies the alignment of hidden Markov models via HHsearch to improve the accuracy of alignment and detection rates. The model with the best confidence and Z-score was selected and visualized using Swiss PDB viewer \[[@ref21]\] and PyMOL molecular graphics system \[[@ref22]\]. Hydrogen bonds were also detected by WHAT IF web server \[[@ref23]\] and PIC web server \[[@ref24]\].

Results {#sec1-3}
=======

Detection of Rare Codon Clusters {#sec3-1}
--------------------------------

Rare and highly rare codons are highlighted in orange and red, respectively. The protein family (Pfam) accession number of ATP8B1 was identified using UniProt database (<http://www.uniprot.org/>). Pfam is a comprehensive collection of protein domains and families represented as multiple sequence alignments and as profile hidden Markov models \[[@ref25]\]. Analysis of this Pfam in Sherlocc program showed that this gene does not have any rare codon cluster. RaCC introduced codons for arginine (AGG, AGA and, CGA), leucine (CTA), isoleucine (ATA), and proline (CCC) with probable problem. Analysis of this gene in this server show some rare codons throughout the gene sequence. The Pfam accession numbers of AT8B1_HUMAN was identified as PF00122 (E1-E2_ATPase. 1 hit) PF16212 (PhoLip_ATPase_N. 1 hit) and PF16209 (PhoLip_ATPase_N. 1 hit) in the UniProt database (<http://www.uniprot.org/>). The results of Sherlocc program \[[@ref15]\] show that this program did not identify any rare codon cluster in AT8B1 ([Table 1](#T1){ref-type="table"}).

###### 

The result of PF07969 ID analysis in Sherlocc program.

  PFAM ID
  --------------------------
  Your query gave 0 match.

Next, the nucleotide sequence of AT8B1_HUMAN was analyzed in ATGme server. This server identifies rare codons and gives several options for codon usage optimization. By the use of codon usage table of Homo sapiens \[gbpri\]: 93487 CDS's (40662582 codons) (<http://www.kazusa.or.jp/codon/cgi-bin/showcodon.cgi?species=9606>), this gene was analyzed and the rare and highly rare codons were shown and highlighted in orange and red, respectively ([Figure 1](#JBPE-9-105-g001.tif){ref-type="fig"}). Moreover, GC and AT contents of this gene were GC%: 45.42, AT%:54.58, calculated by this server.

![Schematic representation of the codon usage and position of rare and highly rare codons in AT8B1_HUMAN gene (displayed in orange and red, respectively)](JBPE-9-105-g001){#JBPE-9-105-g001.tif}

As these findings demonstrate, AT8B1_HUMAN gene has some rare and highly rare codons in which for results refinement, RaCC server was used to introduce the problematic residue codons as Arg, Leu, Ile and Pro. The results show that AT8B1_HUMAN gene has 35 rare codons for Arg, eleven rare codons for Ile, 9 single rare codons for Leu, and 11 rare codons for Pro ([Table 2](#T2){ref-type="table"}). This analysis also revealed AT8B1_HUMAN gene does not have any tandem double or triple repeats of rare Arg codon.

###### 

Schematic representation the position of Arg, Leu, Ile, and Pro in the AT8B1_HUMAN gene. These residues have rare codons, displayed in red, blue, green, orange, and red, respectively.

  Amino Acid   Codon                                       Codon position
  ------------ ------------------------------------------- -------------------------------------------------------------------------
  Arg          AGA                                         5-59-118-252-271-282-327-330-437-608-652-775-817-827-832-1024-1032-1141
  CGA          46-631-930-941-952-1164-1193                
  AGG          176-185-301-541-563-572-586-768-773-1246-   
  Leu          CTA                                         145-272-279-654-710-842-935-951-1027
  Ile          ATA                                         108-319-475-490-742-910-945-1020-1050-1082-1122
  Pro          CCC                                         23-147-268-381-401-433-553-793-870-996-1159

Afterwards, rare codon clusters (RCC) were detected and visualized in LaTcOm web tool \[[@ref18]\]. In LaTcOm, three algorithm of % MINMAX, sliding window and MSS were employed. Codon usage table from CUTG database \[[@ref19]\] was used as a reference in these three algorithms, and the situation of rare codon clusters were identified in AT8B1_HUMAN gene using MSS, minmax and sliding window algorithms ([Figure 2; A, B and C](#JBPE-9-105-g002.tif){ref-type="fig"}).

![The position of rare codon clusters in AT8B1_HUMAN gene. Detection of RCC using MSS algorithm (A), minmax algorithm (B), and sliding window method (C)](JBPE-9-105-g002){#JBPE-9-105-g002.tif}

These results indicated different features of these three algorithms. As shown, MSS detected 2 clusters, Minmax detected 10 and sliding_window detected 16 clusters. It is important to note that the cluster length selected for all of algorithms was 21. The characteristics and positions of these RCCs in the AT8B1_HUMAN gene are reported in [Table 3](#T3){ref-type="table"}.

###### 

The rare codon clusters characteristics in AT8B1_HUMAN gene retrieved from LaTcOm web tool

  RCC identification Algorithms   Cluster length   Position of clusters   Score (per position)   Expected value
  ------------------------------- ---------------- ---------------------- ---------------------- ----------------
  MSS                             21               276-301                0.205                  0.996
  1018-1044                       0.300            -0.099                                        
  Min- max                        21               74-111                 0.061                  0.057
  186-211                         0.152            0.139                                         
  259-325                         0.128            0.115                                         
  472-509                         0.289            0.261                                         
  611-640                         0.432            0.391                                         
  654-674                         0.673            0.610                                         
  901-935                         0.475            0.427                                         
  938-968                         0.609            0.550                                         
  1010-1064                       0.417                                                          
  1198-1224                       0.927                                                          
  Sliding window                  21               1-11                   -0.274                 
  46-82                           -0.305                                                         
  85-105                          0.042            -0.834                                        
  117-142                         -0.080           -0.827                                        
  265-319                         -0.132           -0.604                                        
  323-366                         -0.147           -0.907                                        
  473-544                         -0.066           -0.779                                        
  580-643                         -0.094           -1.081                                        
  650-670                         -0.081           -3.486                                        
  748-784                         -0.144           -2.166                                        
  789-811                         -0.437           -3.693                                        
  901-983                         -0.306           -1.139                                        
  1012-1059                       -0.474           -0.203                                        
  1073-1112                       -0.147           -0.237                                        
  1115-1176                       -0.189                                                         
  1187-1223                       -0.415                                                         

Later, for results better understanding, we focused on the rare codons in relation to mutations in ATP8B1 responsible for PFIC1 disease. After their comparison, three clusters located at codon sequence in the ATP8B1 structure were selected and studied precisely. These regions were identified in most of the findings and outputs obtained from various web servers.

### Studying Rare Codons in ATP8B1 Structure {#sec3-1-1}

Knowledge of 3D structure is a useful prerequisite for understanding the proteins functions and studying rare codons in 3D protein structure as a cornerstone in many aspects of modern biology. One possible role of rare codon \[[@ref14]\] is to play a regulating role in folding catalytically important domains, in protein structure and indirectly folding \[[@ref15],[@ref26]\]. As mentioned, 6 rare codon clusters were identified in AT8B1_HUMAN gene. Specific studies show that crystal structures of ATP8B1 protein have not been reported. For precise studying of the location and role of rare codons, it is necessary to gain 3D models from these sequences. In the beginning, to obtain the relative assessment from this protein, the sequence of ATP8B1 protein was analyzed in Predictprotein server ([Figure 3](#JBPE-9-105-g003.tif){ref-type="fig"}).

![Schematic representation properties of ATP8B1 sequence in Predictprotein server. A) The amino acid composition. B) Red diamond in line 2 shows the position of binding site. At line 3, the red and blue color rectangular show the α-helix and β-sheet, respectively. In line 4, blue, yellow and white color rectangular show the buried, exposed and intermediate, region respectively. Helical transmembrane region shows with Purple Square at line 5. The disordered regions show with green rectangular in the last line.](JBPE-9-105-g003){#JBPE-9-105-g003.tif}

Consequently, by submitting sequences of ATP8B1 in I-TSSAR and Phyre2 Web Servers, 3D models of these proteins were obtained. The crystal structures of selected proteins as templates in these servers approximately have \<200 amino acids in comparison with ATP8B1 protein. So, these extra segments were predicted as disordered regions (I-TSSAR results) or were not included in the final structure of model (Phyre2 results). I-TSSAR Web Server generated five models and best model showed -1.82 value of overall C-score, 0.49±0.15 value of TM-Score and Exp. RMSD was 14.1±3.9 ([Figure 4A](#JBPE-9-105-g004.tif){ref-type="fig"}). Phyre2 Web Servers used the crystal structure of the sodium-potassium pump in the e2.2k+.pi2 state as top template and the structure contents were as disordered (23%), Alpha helix (47%), Beta strand (15%) and TM helix (19%) ([Figure 4B](#JBPE-9-105-g004.tif){ref-type="fig"}).

![The ribbon diagram of ATP8B1 modeled in I-TSSAR (A) and Phyre2 Web Servers (B).](JBPE-9-105-g004){#JBPE-9-105-g004.tif}

Since the selected templates have fewer amino acids, these extra segments were predicted as disorder loops in I-TSSAR Web Servers (A) and were not included in the final structure in Phyre2 Web Servers. Thus, the best model of Phyre2 Web Server was used in the study of rare codon and mutation in the structure of ATP8B1. Following, the physiochemical properties of ATP8B1 protein was calculated in ProtParam tool ([Table 4](#T4){ref-type="table"}).

###### 

In silico physico-chemical properties of ATP8B1 protein obtained from ProtParam tool. \* First value is based on the assumption both cysteine residues form cystine and the second assumes that both cysteine residues are reduced.

  Parameters                                     ATP8b1
  ---------------------------------------------- ---------------
  Theoretical pI                                 6.77
  Molecular weight                               143695.4
  Sequence length                                1251
  Extinction coefﬁcients (M-1 cm-1at 260 nm)\*   186210-184960
  Asp + Glu                                      153
  Arg + Lys                                      150
  Instability index                              40.60
  Grand average of hydropathicity                -0.241
  Aliphatic index                                87.32

ATP8B1 has 1251 residues, in which rare codons are distributed throughout the protein sequence. Based on modelling results, these rare codons are located in different regions of ATP8B1 structure. Furthermore, analyzing the 3D model of ATP8B1 structure in PIC server showed the interaction of these residues with other residues ([Figure 5](#JBPE-9-105-g005.tif){ref-type="fig"}). A spectrum of mutations in ATP8B1 responsible for PFIC1 disease was presented previously. Next, the situation of some important mutations in relation to rare codons were studied in the ATP8B1 structure. Analyzing the 3D model of ATP8B1 demonstrated that Arg^600^ residue (detected as rare codon in our analysis) forms a hydrogen bond with ASN^597^ ([Figure 5](#JBPE-9-105-g005.tif){ref-type="fig"}). But, with mutation of this residue to Trp or Gln, this hydrogen bond was disrupted. The significance of this change is that the mutation caused the BRIC disorder in patients with this mutation in the ATP8B1 gene ([Figure 5](#JBPE-9-105-g005.tif){ref-type="fig"})

![A) The ribbon diagram of ATP8B1, with location of Arg^600^ (rare codon residues) in blue color. The Arg^600^ residue form the hydrogen bond with Gln^597^ (B), mutation of Arg^600^ to Gln^600^ (C) and Trp^600^ (D) are shown.](JBPE-9-105-g005){#JBPE-9-105-g005.tif}

The non-covalent interactions was calculated by WHAT IF \[[@ref23]\] and PIC \[[@ref24]\] web servers, and the results are shown in [Table 5](#T5){ref-type="table"}.

###### 

The characteristics of non-covalent interactions of Arg^600^ with Gln^597^ (Dd-a= Distance Between Donor and Acceptor, Dh-a= Distance Between Hydrogen and Acceptor, A(d-H-N)= Angle Between Donor-H-N , A(a-O=C) = Angle Between Acceptor-O=C, MO=Multiple Occupancy).

  DONOR   ACCEPTOR   PARAMETERS                                                   
  ------- ---------- ------------ ----- ----- ------ ---- ------ ------ --------- ---------
  POS     RES        ATOM         POS   RES   ATOM   MO   Dd-a   Dh-a   A(d-HN)   A(aO=C)
  600     ARG        N            597   ASN   O      1    3.45   3.03   107.09    100.51

Another missense mutation (2197 G\>A) was detected in the nucleotide sequence of AT8B1_HUMAN gene that resulted in PFIC ([Figure 6A](#JBPE-9-105-g006.tif){ref-type="fig"}) In this mutation, the codon sequence of Gly^733^ (GGA) changed to Arg^733^ (AGA) diagnosed as rare codon. This substituted residue, Arg^733^ residue constitutes hydrogen bonds with Asp^232^, Leu^231^ and Arg^867^ as shown in [Figure 6B](#JBPE-9-105-g006.tif){ref-type="fig"}.

![The ribbon diagram of ATP8B1, with location of Gly^733^ (A) and mutation to rare codon of Arg^733^ (B) in blue color. The hydrogen interaction of these residues with Asp^232^, Leu^231^ and Arg^867^ are shown in yellow color.](JBPE-9-105-g006){#JBPE-9-105-g006.tif}

The non-covalent interactions were calculated by PIC web servers, and the results are shown in [Table 6](#T6){ref-type="table"}.

###### 

The characteristics of non-covalent interactions of Gly^733^ and Arg^733^ with other residues.

  DONOR   ACCEPTOR   PARAMETERS                                                   
  ------- ---------- ------------ ----- ----- ------ ---- ------ ------ --------- ---------
  POS     RES        ATOM         POS   RES   ATOM   MO   Dd-a   Dh-a   A(d-HN)   A(aO=C)
  867     ARG        NH1          733   Gly   O      1    2.93   2.16   128.60    150.57
  867     ARG        NH1          733   Gly   O      2    2.93   3.45   52.14     150.57
  733     ARG        NE           231   LEU   O      \-   3.22   2.52   127.01    121.45
  867     ARG        NH1          733   ARG   O      1    2.93   2.16   128.60    150.57
  733     ARG        NH1          232   ASP   OD1    1    2.97   3.34   60.82     999.99
  733     ARG        NH2          289   ASP   OD1    2    3.40   2.40   163.31    999.99

Similarly, in PFIC patients, the missense mutation (2674 G\>A) was detected and analyzed ([Figure 7A](#JBPE-9-105-g007.tif){ref-type="fig"}). In this mutant, the codon sequence of Gly^892^ (GGA) changed to rare codon of Arg^892^ (AGA). This Arg^8923^ residue constitutes hydrogen bonds with Phe^452^, Leu^731^, Asp^897^ and Glu^914^ as shown in [Figure 7B](#JBPE-9-105-g007.tif){ref-type="fig"}.

![The ribbon diagram of ATP8B1, with location of Gly^892^ (A) and mutation to rare codon of Arg^892^ (B) (blue color). The hydrogen interaction of these residues are shown in yellow color.](JBPE-9-105-g007){#JBPE-9-105-g007.tif}

The results of this analysis are shown in [Table 7](#T7){ref-type="table"}.

###### 

The characteristics of non-covalent interactions of Gly^733^ and Arg^733^ with other residues.

  DONOR   ACCEPTOR   PARAMETERS                                                       
  ------- ---------- ------------ ----- ----- ------ ------ ------ -------- --------- ---------
  POS     RES        ATOM         POS   RES   ATOM   MO     Dd-a   Dh-a     A(d-HN)   A(aO=C)
  892     GLY        N            908   VAL   O      3.08   2.31   134.82   156.35    
  914     GLU        OE2          892   GLY   O      1      3.41   3.96     51.99     168.78
  892     ARG        NH2          452   PHE   O      1      3.46   2.79     122.31    81.75
  892     ARG        NH1          731   LEU   O      2      2.53   1.53     162.16    149.29
  914     GLU        OE2          892   ARG   O      1      3.41   3.96     51.99     168.78
  892     ARG        NH1          897   ASP   OD1    1      3.21   2.37     136.91    999.99

Also, Gly^1040^ forms hydrogen bond with His^356^, His^357^ as the missense mutation (2674 G\>A) was detected and analyzed ([Figure 8A](#JBPE-9-105-g008.tif){ref-type="fig"}). At missense mutation in PICF patient, the codon sequence of Gly^1040^ (GGG) changes to rare codon of Arg^1040^ (AGG). This Arg^892^ residue constitutes hydrogen bonds with Phe^452^, Leu^731^, Asp^897^ and Glu^914^ shown in [Figure 8B](#JBPE-9-105-g008.tif){ref-type="fig"}.

![The ribbon diagram of ATP8B1, with location of Gly^1040^ (A) and Arg^1040^ rare codon residue (B) in blue color. The residues that form hydrogen interaction are shown in red color.](JBPE-9-105-g008){#JBPE-9-105-g008.tif}

The results of this analysis are shown in [Table 8](#T8){ref-type="table"}.

###### 

The characteristics of non-covalent interactions of Gly^1040^ and Arg^1040^ with other residues. The Arg^1040^ has a similar interaction with Ser^1036^, leu^1037^, Leu^1042^, Thr^1043^ and Ser^1044^

  DONOR   ACCEPTOR   PARAMETERS                                               
  ------- ---------- ------------ ------ ----- ------ ------ ------ --------- ---------
  POS     RES        ATOM         POS    RES   ATOM   Dd-a   Dh-a   A(d-HN)   A(aO=C)
  1040    GLY        N            1036   SER   O      3.01   2.13   147.85    158.16
  1040    GLY        N            1037   LEU   O      3.31   2.74   117.05    98.24
  1042    LEU        N            1040   GLY   O      3.37   3.44   77.23     75.69
  1043    THR        OG1          1040   GLY   O      2.41   9.99   999.99    116.60
  1044    SER        OG1          1040   GLY   O      3.14   9.99   999.99    137.57
  1040    ARG        NH2          1080   LEU   O      3.40   2.62   131.29    127.28
  1040    ARG        NE           1087   GLN   OE1    3.21   4.02   31.64     999.99
  1040    ARG        NH2          988    TYR   OH1    3.22   3.95   40.29     999.99

Discussion {#sec1-4}
==========

Progressive familial intrahepatic cholestasis (PFIC1) refers to autosomal- recessive liver disorders of childhood in which cholestasis of hepatocellular origin often presents in the neonatal period or first year of life and leads to liver failure and death \[[@ref1],[@ref27]\]. Three types of progressive familial intrahepatic cholestasis including type 1 (PFIC1), type 2 (PFIC2) and type 3 (PFIC3) are related to mutations in hepatocellular transport-system genes involved in bile formation \[[@ref28]\].

ATP8B1 deficiency is an autosomal recessive liver disease caused by mutations in ATP8B1, encoding a P-type ATPase \[[@ref29]\]. Deficiency of ATP8B1 in the hepatocyte leads to loss of asymmetric distribution of phospholipids in the canalicular membrane, decreasing both membrane stability and function of transmembrane transporters such as ABCB11, the bile salt export pump, resulting in intrahepatic cholestasis (IC) \[[@ref30]\]. PFIC1 also known as Byler disease, is characterized by cholestasis often arising in the neonatal period leading to death due to liver failure \[[@ref31]\].

Previously, the detection of rare codons was performed on the genome and proteins of cytosine deaminase and HCV (article in press). Furthermore, no similar analyses have been reported on ATP8b1. It is very important to recognize the cause of disease in genetic disorders of the liver such as "rare" codons infrequently used by cells. Besides, in drug research and designing, considering the structural situation, the hidden computational biology information and the roles of specific residues in catalytic function are critical. In spite of the large number of studies on PFIC1, there are a number of unresolved issues regarding the structure of ATP8b1. In this bioinformatic study, several web servers were used for detecting mutation and rare codons in the structure of ATP8b1.

The Sherlocc program identified no rare codon clusters in the ATP8b1 protein family with three Pfam IDs of PF00122, PF16212 and PF16209. Following, rare and highly rare codons were identified using ATGme web server. The results indicated that ATP8b1 had 67 rare codons and 11 very rare codons. These rare and very rare codons can play a critical role in folding protein chain. Moreover, AT8B1_HUMAN gene was analyzed in RaCC server which focused on Arg, Leu, Ile and Pro. Results showed that AT8B1_HUMAN gene had 35 rare codons of Arg, 11 single rare codons for Ile, 9 rare codons for Leu and 11 rare codons for amino acid Pro. Later, rare codon clusters of AT8B1_HUMAN gene were also detected using LaTcOm web tool (17).

Results of this study showed that 2 rare codon clusters were identified via MSS, 10 rare codon clusters via minmax and 16 rare codon clusters via sliding_window algorithm. The difference of outputs is because these algorithms have different primary databases. The results also showed the high frequency of rare codons that make susceptible this gene in mutation and disrupt the proper folding of the protein. An initial review of location of these Arg residues and the large number of formed hydrogen bonds demonstrate that these residues have a critical role in proper folding of ATP8b1. Because the large number of rare codons are difficult to consider, we focus on some rare codons related to mutation causing PFIC1. Results summarization led to choose three rare codons for precisely studying the structure of ATP8b1, 3D structure of ATP8b1 which was modelled by Phyre2 and I-TSSAR Web Server.

The initial analysis showed that some regions of this protein have disorder structure. These regions were modelled as disordered in I-TSSAR or not included in final structure of model as shown in Phyre2 results. Disordered regions are dynamically flexible and are distinct from irregular loop secondary structures which are static in solution. Phyre2 prediction has been made by the knowledge-based Disopred method. The superimposition of these models from Phyre2 and I-TSSAR show high degree of similarity. We used Phyre2 results in structure study because some rare codons were difficult to study in model from I-TSSAR which has the Disordered regions, for which results were not reported.

Structure analyses revealed that these rare codons and mutations were scattered across different regions of the ATP8b1 structure. Results of 3D modelling indicated that Arg^600^ residue forms some hydrogen bonds with other residues, with which mutation to the Gln600 and Trp600 in PFIC1 patients, these hydrogen bonds changed, and this affects the rate of folding that may affect the proper folding and catalytic activity of ATP8b1 ([Figure 4](#JBPE-9-105-g004.tif){ref-type="fig"}). It seems that this residue has a critical role in the process of protein folding, in such positions to grantee the proper folding was necessary to slow down the rate of the folding. These effects may result in inefficiency of ATP8b1 and subsequently PFIC1. However, other hypothesis can be considered for the pathogenicity causes of this mutation.

Previously, three mutations that caused the PFIC1 were identified in Gly location at Gly^733^, Gly^892^ and Gly^1040^. All of these Glys were mutated to Arg in PFIC1 patients. Arg has six codons including AGG, AGA, CGT, CGC, CGA and CGG. In PFIC1 patients, the Gly codons, in these position, were mutated to Arg (AGA^733^, AGA^892^ and AGG^1040^) with low frequency (identified as rare codons). These mutations reduced the rate of protein folding in these residues and may be interfering with proper rate of folding affecting the final structure and catalytic activity. Furthermore, these Args can form some hydrogen bonds involving different parts of the protein and may disrupt the ATP8b1 folding. Besides, Gly contains no side chain and has the ability to fit within the structure, conveniently. In comparison with Gly, the Arg has a large and bulky side chain. With mutation of Gly to Arg, these may create the structural repulsion that interfere with folding and functional activity of PFIC1. All these hypotheses have a negative effect on the correct activity of ATP8b1 resulting in PFIC1 disease. Meanwhile, experimental evidence as introducing another mutation in these position is needed for our theoretical studies confirmation; other mutations and rare codons should undergo further study.

Next, by the use of molecular docking as a prerequisite of performing structure-based virtual screening (SBVS) \[[@ref32]\], the residues involved in the binding site and enzyme's activity of ATP8b1 will be analyzed. This has profound applications in drug discovery. Therefore, we tried to introduce zinc ion in the substrate-docking region to determine the proper cytosine binding site in further studies.

We have previously modeled the structure of a number of proteins and have a good experience in homology modeling technique \[[@ref33]-[@ref36]\]. In this regard, the RCCs properties in the protein and genome of ATP8b1 was evaluated.

Conclusion {#sec1-5}
==========

Our study identified nearly some of these regions that might involve in the substrate binding site or proper folding. Our data showed that rare codon positions might have an essential role in folding and activity of ATP8b1. This study may also provide new insights into drug design for the treatment of PFIC1 in the future.
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